Početna › Ulcerativni kolitis › Washington › Tacoma
Kliničke studije za Ulcerativni kolitis u gradu Tacoma, WA
15 studija za Ulcerativni kolitis traži sudionike na lokacijama u gradu Tacoma i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
U tijeku regrutacijaFaza 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Site 019, Tacoma
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Site US-029, Tacoma
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
- GI Alliance Tacoma, Tacoma
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
U tijeku regrutacijaFaza 2/3
- MultiCare Health System, Tacoma
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
U tijeku regrutacijaFaza 3
- Washington Gastroenterology - Tacoma, Tacoma
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
U tijeku regrutacijaFaza 4
- Washington Gastroenterology- GIA, Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
- GI Alliance Tacoma, Tacoma
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Digestive Health Specialists, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
U tijeku regrutacijaFaza 3
- MultiCare Institute for Research & Innovation, Tacoma
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
U tijeku regrutacijaOpažajna studija
- Washington Gastroenterology, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
U tijeku regrutacijaFaza 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
U tijeku regrutacijaFaza 2
- Mirador Therapeutics Selected Site, Tacoma
Studije za Ulcerativni kolitis u drugim gradovima
- New York City, NY23 studija
- Orlando, FL22 studija
- Miami, FL21 studija
- Houston, TX17 studija
- San Antonio, TX16 studija
- Chicago, IL15 studija
- San Diego, CA15 studija
- Tyler, TX14 studija
- Colorado Springs, CO14 studija
- Los Angeles, CA13 studija
- St. Louis, MO13 studija
- Washington, DC12 studija
Ostale studije u gradu Tacoma
- Nemikrocelularni karcinom pluća20 studija
- Rak dojke18 studija
- Multipli mijelom13 studija
- Rak prostate11 studija
- Crohnova bolest11 studija
- Metastatski karcinom9 studija
- Kolorektalni rak9 studija
- Melanom7 studija
- Rak jajnika7 studija
- Rak (sve vrste)6 studija
- Rak gušterače6 studija
- Debljina6 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.